KPC Pharmaceuticals,Inc. Company Description

KPC Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally.

It offers artemether, panax notoginseng, and gastrodine series drugs, as well as Chinese medicines and ethnic drugs under the Luotai, Tianxuanqing, Artemedine, Artem, and Arco brand names for treating cardio-cerebral-vascular and nervous system diseases, as well as malaria.

The company also provides Dai medicines; antibiotics, chemical medicinal raw materials, chemical pharmaceutical preparations, traditional Chinese medicinal materials, biological products, biochemical drugs, and health foods; Amoxicillin, Cefaclor, Alfacalcidol, Artz, Snaplets, and Ribavirin spray products; glycyrrhizic acid; and GLP-1, a long-acting hypoglycemic drug.

It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015.

KPC Pharmaceuticals, Inc. was founded in 1951 and is based in Kunming, the People's Republic of China.

KPC Pharmaceuticals,Inc.

Country	China
Founded	1951
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
Employees	5,072
CEO	Wei Yan

Contact Details

Address: No.166 Keyi Road Kunming China
Phone	86 871 6831 9868

Stock Details

Ticker Symbol	600422
Exchange	Shanghai Stock Exchange
Fiscal Year	January - December
Reporting Currency	CNY
ISIN Number	CNE0000015P8
SIC Code	2834

Key Executives

Name	Position
Wei Yan	President and Vice Chairman
Sun Zhi Qiang	Financial Director
Zhang Mengxun	Board Secretary and General Counsel
JunFeng Liu	Senior Vice President
Li Meng	Executive Vice President
Cheng Sun	Vice President
Kai Xi	Vice President
Tong Gao	Vice President
Li Chun Li	Vice President